Denne siden er tilgjengelig på flere språk
Select Language

IPO Acacia Pharma

Back

Listing of Acacia Pharma

Julian Gilbert, CEO, opens the trading day in Brussels.

Acacia Pharma specializes in the research and development of supportive care medicines. The products are intended to support the side effects of anti-cancer treatments (including nausea and vomiting drugs).

To find out more about Acacia Pharma:  www.acaciapharma.com